Maxcyte Inc is a biotechnology company focused on developing and commercializing innovative cell-based therapies and drug discovery solutions
The company specializes in providing its proprietary cell-engineering platform, which enables the rapid development and manufacturing of complex, cell-based therapeutics. By facilitating the delivery of genetic material into various types of cells, Maxcyte aims to enhance the capabilities of researchers and developers in the biopharmaceutical industry, ultimately contributing to the advancement of new treatments for a variety of diseases, including cancer and genetic disorders.
Stocks surged higher as investors reacted positively to dovish tariff news; next week will be highlighted by the Federal Reserve meeting and some tech earnings
MaxCyte's proprietary Flow Electroporation technology enables companies like Vertex and CRISPR Therapeutics to get FDA approved for their gene-editing therapy.
Shares of Taysha Gene Therapies, Inc. (NASDAQTSHA) rose sharply in today’s pre-market trading after the company reported a year-over-year increase in FY23 EPS results.
Top Wall Street analysts changed their outlook on these top names. For a complete view of all analyst rating changes, including upgrades and downgrades, please see our analyst ratings page.
MaxCyte Inc (NASDAQMXCT) shares plummeted after the company released preliminary Q3 revenue of $7.8 million – 8.0 million, a Y/Y decrease of 25 -27%, due to continued reduced
U.S. stocks traded slightly lower toward the end of trading, with the Dow Jones index falling around 40 points on Thursday. The Dow traded down 0.12% to 33,088.44 while the NASDAQ fell 0.23% to 13,206.10. The S&P 500 also fell, dropping, 0.23% to 4,253.86.
Gainers Orchard Therapeutics plc (NASDAQORTX) shares climbed 97.7% to $15.98 after the company agreed to be acquired by Japan's Kyowa Kirin for $16.00 per ADS in cash plus an additional contingent value right of $1.00 per ADS.
U.S. stocks traded lower midway through trading, with the Dow Jones index falling more than 100 points on Thursday. The Dow traded down 0.45% to 32,980.31 while the NASDAQ fell 0.62% to 13,154.24. The S&P 500 also fell, dropping, 0.57% to 4,239.60.
